EPR investigation of in vivo inhibitory effect of guanidine compounds on nitric oxide production in rat tissues

Journal of Physiology and Pharmacology

Volumn 54, Issue 3, 2003, Pages 339-347

  Dambrova, Maija ^a   Kirjanova, O ^a   Baumane, L ^a   Liepinsh, E ^a,b   Zvejniece, L ^a,b   Muceniece, R ^b   Kalvinsh, I ^a   Wikberg, J E S ^c  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Aminoguanidine; EPR; Guanabenz; L NAME; Nitric oxide

Indexed keywords

AMINOGUANIDINE; GUANABENZ; GUANIDINE DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; ELECTRON SPIN RESONANCE; HEART; KIDNEY; LIVER; MALE; MEASUREMENT; NONHUMAN; RAT; TESTIS;

ANIMALS; CEREBRAL CORTEX; DITIOCARB; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERROUS COMPOUNDS; GUANABENZ; GUANIDINES; HEART; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; TESTIS;

EID: 0141459561     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Stuart-Smith K. Demystified. Nitric oxide. Mol Pathol 2002; 55: 360-366.
2. Sarkar D, Vallance P, Harding SE. Nitric oxide: not just a negative inotrope. Eur J Heart Failure 2001; 3: 527-534.
3. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure function and inhibition. Biochem J 2001; 357: 593-615.
4. Beck KF, Eberhardt W, Frank S et al. Inducible NO synthase: role in cellular signaling. J Exp Biol 1999; 202: 645-53.
5. Leong SK, Ruan RS, Zhang Z. A critical assessment of the neurodestructive and neuroprotective effects of nitric oxide. Ann N Y Acad Sci 2002; 962: 161-81.
6. Ignarro L. Physiology and pathophysiology of nitric oxide. Kidney Int 1996; 49: S2-S5.
7. Vallence P, Leiper J. Blocking of NO synthesis: how where and why? Nature Rev Drug Disc 2002; 1: 939-950.
8. Muscara MN, Wallace JL. Nitric Oxide V. Therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol 1999; 276: G1313-G1316.
9. Ogden JE, Moore PK. Inhibition of nitric oxide synthase-potential for a novel class of therapeutic agent? Trends Biotechnol 1995; 13: 70-78.
10. Griffith OW and Kilbourn RG. Nitric oxide synthase inhibitors: amino acids. Methods Enzymol 1996; 268: 375-392.
11. Nakatsuka M, Nakatsuka K, and Osawa Y. Metabolism-based inactivation of penile nitric oxide synthase activity by guanabenz. Drug Metab Dispos 1998; 26: 497-501.
12. Kalyanaraman B. Detection of nitric oxide by electron spin resonance in chemical photochemical cellular physiological and pathophysiological systems. Methods Enzymol 1996; 268: 168-187.
13. Nagano T and Yoshimura T. Bioimaging of nitric oxide Chem Rev 2002; 102: 1235-1269.
14. + with diethylthiocarbomate of N-methyl-D-glucamine dithiocarbomate as traps of nitric oxide in animal tissues: comparative investigations. Biochim Biophys Acta 1997; 1336: 225-234.
15. Baumane L, Dzintare M, Zvejniece L, et al. Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy. Acta Anaesthesiol Scand 2002; 46: 378-383.
16. Vanin AF, Mordvintsev PI, Kleshchov AL. Incorporation of nitric oxide in animal organ tissues in vivo Studia Biophysica (in Rus.). 1984; 102: 135-143.
17. Dzintare M, Baumanc L, Meirena D, Lauberte L, Kalvinsh I, Sjakste N. Nitric oxide production in different organs of intact white rats. Baltic J. Lab. Anim. Sci. 2001; 11: 218-224.
18. Lecour S, Maupoil V, Siri O, Tabard A, Rochette L. Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats. J Cardiovasc Pharmacol 1999; 33: 78-85.
19. Holstad M, Jansson L, Sandler S. Inhibition of nitric oxide formation by aminoguanidine: an attempt to prevent insulin-dependent dibetes mellitus. Gen. Pharmac. 1997; 29: 697-700.
20. Vanin AF, Huisman A, van Faassen EF. Iron dithiocarbamate as spin trap for nitric oxide detection: pitfalls and successes. Methods Enzymol 2002; 359: 27-42.
21. Vanin AF, Huisman A, Stroes ES, de Ruijter-Heijstek FC, Rabelink TJ, van Faassen EE. Antioxidant capacity of mononitrosyl-iron-dithiocarbamate complexes: implications for NO trapping. Free Radic Biol Med 2001; 30: 813-824.
22. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996; 51: 383-94.
23. Hasan K, Heesen BJ, Corbett JA, McDaniel ML, et al. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 1993; 249: 101-106.
24. Nilsson BO Biological effects of aminoguanidine: an update. Inflamm Res 1999; 48: 509-515.
25. Taylor BS, Alarcon LH, Billiar TR. Inducible Nitric Oxide Synthase in the Liver. Regulation and Function Biochemistry (Mosc.) 1998; 63: 766-781.
26. Shah RS, Walker BR, Vanov SK, Helfant RH. Guanabenz effects on blood pressure and noninvasive parameters of cardiac performance in patients with hypertension. Clin Pharmacol Ther 1976; 19: 732-737.
27. van Zwieten PA. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics J Hypertens Suppl 1997; 15: S3-8.
28. Noguchi S, Jianmongkol S, Bender AT, Kamada Y, Demady DR, Osawa Y. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase. J Biol Chem 2000; 275: 2376-2380.